Recently, we have demonstrated that esophageal cancer patients with AF1q-positive tumors relapse and die earlier; in this previous study, we demonstrated a positive correlation with the potentially therapeutic WNT and STAT3 target genes CD44 and pYSTAT3 that may be transcriptionally co-activated by AF1q12. Here, CD44 is linked to esophageal cancer.